| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 生物制品(原料药及制剂产品)(元) | 1,223,532,404.36 | 2,360,202,125.13 | 1,484,569,454.56 |
| 特许经营权前期服务(元) | 1,395,594.84 | 99,373,826.49 | 135,174,882.41 |
| 其他(元) | 89,964,846.05 | 148,460,999.43 | 92,526,159.88 |
| 营业成本(元) | |||
| 生物制品(原料药及制剂产品)(元) | 294,534,129.15 | 617,617,965.33 | 357,027,635.49 |
| 特许经营权前期服务(元) | - | - | - |
| 其他(元) | 54,564,641.85 | 79,803,449.86 | 48,776,189.16 |
| 毛利(元) | |||
| 生物制品(原料药及制剂产品)(元) | 928,998,275.21 | 1,742,584,159.80 | 1,127,541,819.07 |
| 特许经营权前期服务(元) | 1,395,594.84 | 99,373,826.49 | 135,174,882.41 |
| 其他(元) | 35,400,204.20 | 68,657,549.57 | 43,749,970.72 |
| 毛利率(%) | |||
| 生物制品(原料药及制剂产品)(%) | 75.93 | 73.83 | 75.95 |
| 特许经营权前期服务(%) | - | - | - |
| 其他(%) | 39.35 | 46.25 | 47.28 |
| 收入构成(%) | |||
| 生物制品(原料药及制剂产品)(%) | 93.05 | 90.50 | 86.70 |
| 特许经营权前期服务(%) | 0.11 | 3.81 | 7.89 |
| 其他(%) | 6.84 | 5.69 | 5.40 |
| 毛利构成(%) | |||
| 生物制品(原料药及制剂产品)(%) | 96.19 | 91.21 | 86.30 |
| 特许经营权前期服务(%) | 0.14 | 5.20 | 10.35 |
| 其他(%) | 3.67 | 3.59 | 3.35 |